Will Hepatitis C Become A New Battleground Between Pharma And Poor Nations? Forbes The episode has been described as a game changer, because the move is expected to encourage still other Indian generic drugmakers to seek licenses for all sorts of medicines in one of the world's largest and fastest-growing markets, although Indian ... |
